Cytori Therapeutics Inc. (CYTX)

0.399 -0.0366 (-8.402%)

IEX Real-Time Price

October 19, 2018 EST.

NASDAQ Capital Market : Healthcare

Prev Close 0.4356

Price Open 0.44

Volume: 364,482

Avg Volume: 871,623

Market Cap: 4.47M

P/E Ratio -0.11

52 Wk Range 0.315-5.487



CYTX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-09-28
10.05M
607,828
0.81
6.05%

2018-09-14
6.57M
964,077
0.69
14.68%

2018-08-31
6.57M
1.02M
0.84
15.49%

2018-08-15
6.57M
570,848
1.18
8.69%




CYTX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-08-14
Q2 2018
AMC
-0.49 (2)
-0.59
-0.10

2018-05-10
Q1 2018
N/A
-0.05 (1)
-0.70
-0.30

2018-03-22
Q4 2017
N/A
-0.07 (1)
-0.70
-0.30

2018-03-08
Q4 2017
N/A
-0.10 (1)
-0.70
-0.30

News

Turkey Fires Back With Tariffs (Wall Street Breakfast Podcast) (2018-08-15 07:44 SeekingAlpha)

Editor's note: Seeking Alpha is proud to welcome WSB Podcast as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more Today's top …

 

Wall Street Breakfast: Turkey Fires Back With Tariffs (2018-08-15 06:38 SeekingAlpha)

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on iTunes , Stitcher and SoundCloud (click the highlighted links). A reeling Turkey has responded to U.S. tariffs with retaliatory duties on U.S. passenger cars, alcohol, tobacco, c…

 

Cytori Therapeutics Inc (CYTX) CEO Marc Hedrick on Q2 2018 Results - Earnings Call Transcript (2018-08-14 22:05 SeekingAlpha)

Cytori Therapeutics Inc (CYTX) Q2 2018 Earnings Conference Call August 14, 2018 05:30 PM ET Executives Marc Hedrick - President and CEO Tiago Giro - CFO Analysts Jason Kolbert - H.C. Wainwright Yale Jen - Laidlaw and Company Presentation Operator Good aftern…

 


Statistics

Shares Outstanding: 11.19M

Top 15 Institution Percent: 3.40

Price To Sales: 1.62

Price To Book: 1.00

Revenue: 1.77M

Gross Profit: 1.29M

Cash: 4.78M

Debt: 13.50M

Return On Assets: -75.64

Return On Equity: -260.39

Profit Margin: N/A

Price History

Beta: 2.24

50-day Moving Avg: 0.45

200-day Moving Avg: 2.10

YTD Change: -84.98

5-day Change: 15.30

1-month Change: -1.00

3-month Change: -55.32

6-month Change: -84.67

1-year Change: -90.63

Revenue Per Share: 0.00

Revenue Per Employee: 47919.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Cytori Therapeutics Inc.

Exchange: NASDAQ Capital Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.cytori.com

Cytori Therapeutics Inc is a specialty therapeutics company. It is committed to providing meaningful and quality therapeutic options with a broad utility that benefit patients and healthcare providers around the world.